Goldman Sachs
NSPR icon

Goldman Sachs’s InspireMD NSPR Stock Holding History

Goldman Sachs’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,908
Closed -$23K – 6835
2025
Q4 		$23K Buy
+12,908
New +$26.9K ﹤0.01% 6337
2021
Q3 		– Sell
-16,832
Closed -$85K – 6426
2021
Q2 		$85K Buy
+16,832
New +$102K ﹤0.01% 5979
2017
Q4 		– Sell
-1
Closed -$6K – 6550
2017
Q3 		$6K Buy
+1
New +$10.7K ﹤0.01% 6563
2015
Q4 		– Hold
0
– -$9K – 7281
2015
Q3 		– Hold
0
– – – 7154
2015
Q2 		– Hold
0
– – – 7107
2015
Q1 		– Hold
0
– – – 6918
2014
Q4 		– Hold
0
– – – 6845
2014
Q3 		– Hold
0
– – – 6378
2014
Q2 		– Hold
0
– – – 6321
2014
Q1 		– Hold
0
– – – 5916
2013
Q4 		– Hold
0
– – – 5979

Other funds holding NSPR

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Goldman Sachs's NSPR Position: Q1 2026 in Review

Goldman Sachs sold out of InspireMD (NSPR) in Q1 2026, closing a stake of 12,908 shares — an estimated $23K sold.

Goldman Sachs first reported a position in NSPR in Q3 2017 and held it in 3 quarters. The position peaked at $85K in Q2 2021. 35 funds tracked by Wall St. Rank hold NSPR as of Q1 2026.

  • Goldman Sachs reported no remaining InspireMD position as of Q1 2026 after selling out during the quarter.
  • Goldman Sachs sold 12,908 InspireMD shares in Q1 2026, an estimated $23K.
  • Goldman Sachs first reported a position in InspireMD in Q3 2017 and held it in 3 quarters.
  • Goldman Sachs's InspireMD position peaked at $85K in Q2 2021.
  • 35 funds tracked by Wall St. Rank held InspireMD as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.